Clinical Prediction Modeling & Public Database Analysis

Home ServicesBioinformatics & Multi-Omics AnalysisClinical Prediction Modeling & Public Database Analysis

Overview

Clinical prediction models are easy to build and hard to build well. We develop statistical and machine-learning models on clinical cohorts or public datasets with the methodology that makes them credible: pre-specified outcomes, principled handling of missing data, sample-size assessment, internal validation by bootstrapping or nested cross-validation, calibration assessment and decision curve analysis. Reporting follows established prediction-model guidance, so the work stands up to methodological review.

Schematic: raw reads become a quantified matrix, then tested differences, then annotated populations — with the statistics matched to the study design.

Key Advantages

Calibration Reported, Not Only Discrimination

A model with good area under the curve can still produce badly wrong probabilities. Calibration plots and metrics are delivered alongside discrimination as standard.

Missing Data Handled Principledly

Multiple imputation with the missingness mechanism assessed is used rather than complete-case analysis, which routinely biases clinical models.

Optimism Corrected

Internal validation uses bootstrapping or nested cross-validation to correct optimism, so the reported performance is not the performance on the data the model learned from.

Clinical Usefulness Assessed

Decision curve analysis shows whether the model would actually improve decisions at plausible thresholds, which statistical performance alone does not establish.

Where This Service Is Used

Developing a diagnostic or prognostic risk model from a clinical cohort

Validating an existing published model in a new population

Analysing public clinical and genomic databases for survival or outcome associations

Building machine-learning models on structured clinical data with interpretable outputs

Producing the statistical analysis and figures for a clinical research manuscript

Methods and Techniques Applied

Data cleaning, variable definition, outlier handling and missing data assessment with multiple imputation

Sample size and events-per-variable assessment relative to model complexity

Model development with regression and machine-learning approaches, with penalisation where appropriate

Variable selection with stability assessment rather than single-pass stepwise procedures

Internal validation by bootstrapping or nested cross-validation, with external validation where data permits

Calibration, discrimination, decision curve analysis and interpretability analysis such as SHAP

What We Need From You

The clinical dataset with a data dictionary and the outcome definition

Candidate predictors and any clinical constraints on which variables may be used in practice

The intended use of the model: screening, prognosis, treatment selection or research only

For public database work, the database and cohort definition, or a request that we propose one

What You Receive

Cleaned analysis dataset with a documented derivation record

Final model with coefficients or the serialised model object and the prediction equation

Performance report covering discrimination, calibration, decision curves and validation results

Interpretability analysis showing which variables drive predictions and in which direction

Manuscript-ready tables, figures, methods text and reproducible analysis code

What We Compute and Report

Model coefficients or the prediction equation, with the derivation fully documented

Discrimination and calibration metrics corrected for optimism through internal validation

Decision curve analysis across clinically plausible thresholds

Variable importance and per-prediction explanation output

Missing data assessment with the imputation approach and its sensitivity

Interpretation and Limitations

Computational predictions prioritise hypotheses; they do not independently establish binding, biological activity, therapeutic efficacy, safety or clinical validity. Performance depends on input quality, target class, the structural evidence available and the applicability domain of the selected methods. Scores used for ranking are comparative devices and should not be read as measured quantities. All deliverables are for research use only and are not intended for diagnostic or therapeutic use.

Specifications

Item	Specification	Notes
Cohort size	100–100,000+	Events per variable assessed before model building
Typical turnaround	3–8 weeks	Including validation and reporting
Model types	Regression, survival, ML ensembles	Chosen for the data and the intended use
Reporting	Guideline-aligned	Following established prediction-model reporting standards

Service Workflow

Step 01

Scientific Consultation

We discuss the objective, the decision it supports and the data you hold. Nothing is quoted before we understand what the result has to answer.

Step 02

Feasibility Review

We check that the data, target class and available structural evidence can support the proposed approach, and say plainly where they cannot.

Step 03

Technical Proposal

Scope, methods, deliverables, timeline and price are confirmed in writing, together with the limitations we expect to report.

Step 04

Computation and QC

The analysis runs on pinned tool versions in a containerised environment, with quality checkpoints and method comparison where that is informative.

Step 05

Report and Follow-Up

You receive the ranked results, the documented methods, the limitations and a proposed validation plan, plus support in interpreting them.

Is This the Right Service for You?

Choose this service when

A prognostic or diagnostic model must meet methodological reporting standards

An existing published model needs validating in a new population

Public clinical or genomic databases need analysing reproducibly

Consider another service when

Imaging features are the predictors

Medical Imaging, Radiomics & Pathomics

Published trial evidence must be synthesised instead

Meta-Analysis & Mendelian Randomization

What Goes Wrong, and How We Handle It

The failure modes that produce confident-looking results which do not survive the next experiment. Each one is designed against rather than discovered afterwards.

Missingness is assessed and multiple imputation applied, with sensitivity analysis on the assumption.

Case Studies

The situation

A team wanted a gradient-boosted model for outcome prediction on 640 patients with 92 events.

What the work involved

Both a penalised regression and the ensemble model were fitted under identical nested cross-validation, with calibration and decision curve analysis computed for each.

What came back

Discrimination was equivalent within confidence intervals, while the regression calibrated better and was interpretable. The simpler model was recommended, with the comparison documented for reviewers.

Illustrative of the shape this work takes. Details are generalised, no client or target is identified, and scope and outcome vary with the system in question.

Questions We Are Asked Before Scoping

Note: ICDMO delivers computational (in silico) services. Results prioritise hypotheses for testing; they do not by themselves establish binding, biological activity, efficacy or safety. All deliverables are for research use only and are not intended for diagnostic or therapeutic use. Downstream experimental work is scoped separately and executed through qualified partners.

Get in Touch
about Clinical Prediction Modeling & Public Database Analysis

Tell us about the target, the data you hold and the decision the result needs to support. A scientist reviews every enquiry and replies within one business day.

Feasibility reviewed before any scope or price is fixed

Methods, parameters, confidence and limitations in every report

Confidentiality agreement available before data is shared